Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Pluristem Therapeutics reports results for PLX-R18 in animal model of ARS

Feb. 18, 2015

Elite Pharmaceuticals plans phase III trial of abuse-deterrent opioid

Feb. 18, 2015

FDA grants fast track designation to intranasal naloxone treatment

Feb. 18, 2015

Scientists at Instituto Italiano di Tecnologia disclose FAAH inhibitors

Feb. 16, 2015

RiVax ricin toxin vaccine protective in macaque model

Feb. 12, 2015

University of Texas discloses new sigma-receptor ligands

Feb. 10, 2015

Biotie Therapies reports topline results from nepicastat study in cocaine dependence

Feb. 2, 2015

Novel treatment for cocaine addiction TV-1380 safe in healthy subjects

Jan. 29, 2015

Takeda launches fomepizole in Japan for ethylene glycol and methanol poisoning

Jan. 27, 2015

Invion reports interim data from phase II trial of oral INV-102 in smoking cessation

Jan. 21, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...